Surfactant therapy improves pulmonary function in infants with Pneumocystis carinii pneumonia and acquired immunodeficiency syndrome

被引:0
|
作者
Creery, WD [1 ]
Hashmi, A [1 ]
Hutchison, JS [1 ]
Singh, RN [1 ]
机构
[1] UNIV OTTAWA, DEPT PEDIAT, OTTAWA, ON K1N 6N5, CANADA
关键词
acquired immunodeficiency syndrome; Pneumocystis carinii pneumonia; human immunodeficiency virus; acute respiratory distress syndrome; surfactant; infant;
D O I
10.1002/(SICI)1099-0496(199711)24:5<370::AID-PPUL10>3.0.CO;2-6
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Pneumocystis carinii pneumonia (PCP) is an important cause of acute respiratory failure in HIV-infected children. PCP may initiate acute respiratory distress syndrome (ARDS) by adversely affecting surfactant physiology. We report improved pulmonary function following administration of bovine lipid extract surfactant to two infants with AIDS-related PCP/ARDS. (C) 1997 Wiley-Liss, Inc.
引用
下载
收藏
页码:370 / 373
页数:4
相关论文
共 50 条
  • [41] PNEUMOCYSTIS-CARINII PNEUMONIA IN THE ACQUIRED IMMUNODEFICIENCY SYNDROME - DIAGNOSIS USING MINILAVAGE SAMPLES
    YOO, OH
    CHOI, HSH
    CUCCO, RA
    DESMOND, E
    LESSER, M
    SOUTHERN MEDICAL JOURNAL, 1989, 82 (07) : 829 - 832
  • [42] HIGH-DOSE CORTICOSTEROID-THERAPY FOR PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME
    AMUNDSON, DE
    MURRAY, KM
    BRODINE, S
    OLDFIELD, EC
    SOUTHERN MEDICAL JOURNAL, 1989, 82 (06) : 711 - &
  • [43] PNEUMOCYSTIS-CARINII ANTIGENEMIA IN ACQUIRED IMMUNODEFICIENCY SYNDROME
    PIFER, LW
    WOLF, BL
    WEEMS, JJ
    WOODS, DR
    EDWARDS, CC
    JOYNER, RE
    JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (07) : 1357 - 1361
  • [44] PNEUMOCYSTIS-CARINII PNEUMONIA PRESENTING AS CAVITATING AND NONCAVITATING SOLITARY PULMONARY NODULES IN PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME
    BARRIO, JL
    SUAREZ, M
    RODRIGUEZ, JL
    SALDANA, MJ
    PITCHENIK, AE
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1986, 134 (05): : 1094 - 1096
  • [45] PERSISTENCE OF PNEUMOCYSTIS-CARINII IN LUNG-TISSUE OF ACQUIRED IMMUNODEFICIENCY SYNDROME PATIENTS TREATED FOR PNEUMOCYSTIS PNEUMONIA
    SHELHAMER, JH
    OGNIBENE, FP
    MACHER, AM
    TUAZON, C
    STEISS, R
    LONGO, D
    KOVACS, JA
    PARKER, MM
    NATANSON, C
    LANE, HC
    FAUCI, AS
    PARRILLO, JE
    MASUR, H
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1984, 130 (06): : 1161 - 1165
  • [46] CORRELATION OF PNEUMOCYSTIS-CARINII CYST DENSITY WITH MORTALITY IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME AND PNEUMOCYSTIS PNEUMONIA
    BLUMENFELD, W
    MILLER, CN
    CHEW, KL
    MAYALL, BH
    GRIFFISS, JM
    HUMAN PATHOLOGY, 1992, 23 (06) : 612 - 618
  • [47] DIAGNOSIS OF PNEUMOCYSTIS-CARINII PNEUMONIA USING TRACHEAL CATHETERS IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME
    MARTIN, WR
    ALBERTSON, TE
    SIEGEL, BJ
    CLINICAL RESEARCH, 1989, 37 (01): : A146 - A146
  • [49] Lung and chest wall mechanics in patients with acquired immunodeficiency syndrome and severe Pneumocystis carinii pneumonia
    DAngelo, E
    Calderini, E
    Robatto, FM
    Puccio, P
    MilicEmili, J
    EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (10) : 2343 - 2350
  • [50] PROGNOSTIC FACTORS AND LIFE EXPECTANCY IN CHILDREN WITH ACQUIRED IMMUNODEFICIENCY SYNDROME AND PNEUMOCYSTIS-CARINII PNEUMONIA
    BERNSTEIN, LJ
    BYE, MR
    RUBINSTEIN, A
    AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1989, 143 (07): : 775 - 778